Patient Registry Software Market Size, Segments| Forecast-2031

Patient Registry Software Market Research, 2031

The global patient registry software market was valued at $993.3 million in 2021, and is projected to reach $2,508.27 million by 2031, growing at a CAGR of 9.7% from 2022 to 2031. A patient registry is a systematic collection of data about individuals who share a certain disease or condition. Patient registries software can be used to monitor outcomes and study best practices in care or treatment of patients. It may pursue a specific, focused research agenda, collecting data for a limited time to answer a specific research question (or questions), or may collect data on an indefinite basis to answer a variety of existing and emerging research questions. Patient registries are playing an increasingly important role in the health care system. Patient registries can be used for a variety of purposes, including monitoring outcomes, studying best practices, and investigating emerging trends. Although patient registries have been around for many years, the use of electronic health records has made it easier than ever to collect and analyze data. As a result, patient registries are expected to play an even more important role in the years to come. Patient registries have traditionally been researcher-generated. Research institutions, academic clinical institutions, or individual research teams establish a registry, using private or Federal funds, for the purpose of observational data collection that can be used for a specific research agenda. These registries may be organized and operated in a variety of forms and formats. They may be operated by a single institution or by a collaborative of multiple institutions or clinics. Researcher-generated patient registries currently exist for a wide range of chronic or rare conditions, including many forms of cancer, diabetes, cystic fibrosis, acute coronary syndrome, and arthritis.

The growth of patient registry software market size is driven by increase in the usage of electronic health records (EHRs), increase in prevalence of chronic diseases, rise in government support for healthcare, surge in geriatric population and increase in potential benefits of patient registry in hospitals and research organizations.

Patient Registry Software Market

Furthermore, the increase in usage of the stored data for post-marketing surveillance and surge in government initiatives to build patient registries helps to increase the patient registry software market growth. However, concerns related to the lack of maintenance of important private data security and privacy of the data and dearth of skilled resources hinder the growth of patient registry software market size. Conversely, the patient registry software market opportunity includes the trend like increase in awareness regarding technologies.

Impact of COVID-19 Pandemic on Patient Registry Software Market

The COVID-19 pandemic affected the patient registry software industry in positive way, like various other medical internet of things (IoT) industries were affected. The rise in the number of COVID-19 patients gave rise to the challenges to the healthcare providers of providing vaccines and products to patients in paralleled manner. The healthcare providers were helped by the registry software to find how many health-related products and vaccines must be needed in a particular area. Moreover, the COVID-19 infection was more prone to the people suffering from chronic respiratory disease, hypertension, cardiovascular disease, diabetes mellitus, and cancer. The administration of COVID-19 medication to these population was harmful for their life. Hence, the healthcare providers took the help of patient registry software to analyze the patient’s condition, and give appropriate medicine to reduce the viral infection. According to the data of Health IT government, the COVID-19 patient registry software allows the number of cases to be managed uniquely across various agencies and organizations. Moreover, the software also supported in nationwide tracking and reporting of infections/immunization. The patient registry software also helped to aggregate the clinical data such as test results and status updates from hospitals, public health departments, labs and physician practices for reporting and tracking of the disease. The patient registry software was also used by the department of Office of the National Coordinator for Health Information Technology (ONC) and American Public Health Association (APHA) as part of the Pandemic Response Hackathon sponsored for studying the data of COVID-19 test results and status in 2020.

Patient Registry Software Market Segmentation

The patient registry software market is segmented into Registry type, Software type, Functionality and End User. On the basis of registry type, the market is divided into disease registry, health service registry and product registry. The disease registry segment is further segmented by type into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. On the basis of software type, the market is classified into standalone and integrated. On the basis of functionality, the market is classified into population health management, health information exchange, patient care management, medical research and clinical studies and others. On the basis of end user, the market is classified into hospitals, government and third party organizations, pharma, biotech and medical device companies and others. Region wise, the market is studied across North America (U.S., Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA).

Market By Registry Type Segment Review

By registry type, the market is classified into disease registry, health service registry and product registry. The disease registry segment is further segmented by type. By type, it is segmented into cardiovascular registry, diabetes registry, cancer registry, rare disease registry and others. The product registry segment is further divided into medical device registry and drug registry. The disease registry segment accounted for the major share of the market in 2021 and is anticipated to continue this trend throughout the forecast period, owing to advantages that are offered by these software and increased adoption of patient registry software.